Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FV5BD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,643
Award facts
- Contract value 100% obligated
- $11,643.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,643.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit vials. The order was issued on October 27, 2025, with an ultimate completion date of November 18, 2025, under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc. will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR, was awarded on November 13, 2025, with a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor capable of fulfilling diverse pharmaceutical requirements for military medical operations globally. The company's established performance across multiple product categories and delivery orders demonstrates its qualification to support recurring federal pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DB26FV5BD?
SPE2DB26FV5BD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FV5BD worth?
The government has obligated $11,643 on SPE2DB26FV5BD.
Is contract SPE2DB26FV5BD an order under another contract?
Yes. SPE2DB26FV5BD is a delivery order under SPE2DB22D9206, an indefinite delivery contract.
Was contract SPE2DB26FV5BD competed?
The extent of competition for SPE2DB26FV5BD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award